Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.22
|
0.306
|
0.256
|
0.253
|
0.256
|
0.253
|
|
|
25.30
|
2.00
|
0.238
|
0.287
|
0.259
|
0.238
|
0.291
|
0.238
|
|
|
48.67
|
5.00
|
0.25
|
0.31
|
0.251
|
0.251
|
0.251
|
0.251
|
|
|
|
|
0.25
|
0.33
|
0.264
|
0.255
|
0.264
|
0.255
|
|
|
284.32
|
2.00
|
0.25
|
0.33
|
0.27
|
0.27
|
0.29
|
0.29
|
|
|
3 010.00
|
4.00
|
0.27
|
0.329
|
0.27
|
0.27
|
0.271
|
0.271
|
|
|
1.90
|
2.00
|
0.27
|
0.33
|
0.27
|
0.27
|
0.29
|
0.27
|
|
|
280.50
|
5.00
|
0.27
|
0.33
|
0.262
|
0.262
|
0.262
|
0.262
|
|
|
|
|
0.251
|
0.314
|
0.262
|
0.262
|
0.316
|
0.316
|
|
|
316.00
|
2.00
|
0.259
|
0.301
|
0.264
|
0.264
|
0.31
|
0.31
|
|
|
1 550.00
|
4.00
|
BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids.